Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,244 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

40,244 Papers indexed
1,440 Papers AI scored
40,244 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-08 10:15 AM
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40244 results
D
Primary intraosseous cavernous hemangioma of the clivus in a pediatric patient: A case report and review of the literature.
PMID 40469341 Published: 2025-05-09 Ingested: 2026-08-02 12:03 AM Surgical neurology international
AI -
Standard 53.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 44.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

D
Maxillary Mesenchymal Chondrosarcoma Affecting A Pediatric Patient: Case Report Showing Long-Term Follow-Up and Detailed Literature Review.
PMID 40453623 Published: 2025-02-09 Ingested: 2026-08-02 12:03 AM Journal of maxillofacial and oral surgery
AI -
Standard 53.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 44.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 44.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

D
A rare presentation of pediatric germinoma mimicking optic pathway glioma: illustrative case.
PMID 40354762 Published: 2025-05-12 Ingested: 2026-08-02 12:04 AM Journal of neurosurgery. Case lessons
AI -
Standard 53.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 44.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

D
A Case of Adult-Onset Atypical Teratoid/Rhabdoid Tumor With Extracranial Metastasis.
PMID 40291196 Published: 2025-03-26 Ingested: 2026-08-02 12:04 AM Cureus
AI -
Standard 53.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 44.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

D
Biotemplated Diatom Microrobots for Dual-Drug Delivery in Targeted Neuroblastoma Therapy.
PMID 40238656 Published: 2025-04-16 Ingested: 2026-08-02 12:04 AM ACS applied materials & interfaces
AI -
Standard 53.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.3/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 49.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

D
A Case of Severe Early Childhood Caries Occurring in a Childhood Cancer Patient.
PMID 40150544 Published: 2025-02-20 Ingested: 2026-08-02 12:03 AM Children (Basel, Switzerland)
AI -
Standard 53.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 44.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

D
Burkitt's lymphoma presenting as acute dacryocystitis in a 14-year-Old male with ataxia telangiectasia: A case report and review of the literature.
PMID 40115528 Published: 2025-02-24 Ingested: 2026-08-02 12:03 AM American journal of ophthalmology case reports
AI -
Standard 53.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 44.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

Previous
Page 2763 of 3354
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic